NorthWest Biotherapeutics Inc (NWBO)

[HyGro]

Well many investors are not buying the Phase 3 trial -- share price is down ~50% in 52 weeks after the TLD. That is clearly a "big picture." I've been in biopharma 20+ years and hold 20+ biotech stock. The big picture has only one real hurdle that makes or breaks a biotech -- a successful pivotal trial that lead to commercial approval. Nothing else matters. Many biotechs have quality contract manufacturers, as has been the case with NWBO. All management has done is finance LP's contract manufacturing business in UK.

My focus has been approvability, and that's clearly an serious issue with NWBO.